Healthcare -
Biotechnology - NASDAQ - US
$ 29.935
0.69 %
$ 3.72 B
Market Cap
-14.75
P/E
APLS - CASH FROM OPERATIONS
Cash from Operations APLS - Apellis Pharmaceuticals, Inc.
-595 M
LAST VALUE
-2.77%
2 YEAR CAGR
-35.29%
5 YEAR CAGR
-67.39%
10 YEAR CAGR